Cargando…

Prospective evaluation of prognostic factors in operable breast cancer.

In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawkins, R. A., Tesdale, A. L., Killen, M. E., Jack, W. J., Chetty, U., Dixon, J. M., Hulme, M. J., Prescott, R. J., McIntyre, M. A., Miller, W. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074769/ https://www.ncbi.nlm.nih.gov/pubmed/8912547

Ejemplares similares

Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
por: Hawkins, R A, et al.
Publicado: (2002)

Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance.
por: Hawkins, R. A., et al.
Publicado: (1991)

Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?
por: Hawkins, R. A., et al.
Publicado: (1990)

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.
por: Hawkins, R. A., et al.
Publicado: (1988)

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines.
por: Langdon, S. P., et al.
Publicado: (1990)

Cyclic AMP binding proteins and prognosis in breast cancer.
por: Miller, W. R., et al.
Publicado: (1990)

Primary systemic therapy for operable breast cancer.
por: Anderson, E. D., et al.
Publicado: (1991)

Change in the oestrogen receptor status of breast cancer with age--comparison of two types of assay.
por: Gaskell, D. J., et al.
Publicado: (1992)

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1998)

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
por: Cameron, D. A., et al.
Publicado: (1996)

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
por: Anderson, E. D., et al.
Publicado: (1989)

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1990)

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
por: Cameron, D. A., et al.
Publicado: (1997)

Anastrozole (‘Arimidex’) blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer
por: Miller, W R, et al.
Publicado: (2002)

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
por: Anderson, T J, et al.
Publicado: (2002)

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.
por: Stewart, H. J., et al.
Publicado: (1996)

Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study
por: Shardlow, Adam, et al.
Publicado: (2016)

Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use.
por: Bartlett, J. M., et al.
Publicado: (1996)

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.
por: Mackay, J., et al.
Publicado: (1988)

Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3
por: Shardlow, Adam, et al.
Publicado: (2017)

pS2 is an independent factor of good prognosis in primary breast cancer.
por: Thompson, A. M., et al.
Publicado: (1993)

Integrin-dependent Control of Translation: Engagement of Integrin α(IIb)β(3) Regulates Synthesis of Proteins in Activated Human Platelets
por: Pabla, Ravinder, et al.
Publicado: (1999)

Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
por: Lindemann, Stephan, et al.
Publicado: (2001)

Locally advanced breast cancer: report of phase II study and subsequent phase III trial.
por: Rodger, A., et al.
Publicado: (1992)

A prognostic index for operable, node-negative breast cancer
por: McCallum, M, et al.
Publicado: (2004)

Is Extirpation of the Cancerous Uterus a Justifiable Operation?
por: McIntyre, John H.
Publicado: (1891)

The Prospects for Specialist Registrars
por: McIntyre, Alistair S
Publicado: (2000)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Security operations center: building, operating, and maintaining your SOC
por: Muniz, Joseph, et al.
Publicado: (2016)

The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study
por: Shardlow, Adam, et al.
Publicado: (2020)

The predictive value of serial acute physiology score (APS) and simplified acute physiology score II (SAPS II) in post-operative liver transplant patients
por: Arabi, Y, et al.
Publicado: (2000)

Post-operative atrial fibrillation after cardiac surgery: Challenges throughout the patient journey
por: McIntyre, William F.
Publicado: (2023)

Oestradiol-17 beta and prolactin levels in rat peripheral plasma.
por: Hawkins, R. A., et al.
Publicado: (1975)

Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer.
por: Watson, D. M., et al.
Publicado: (1987)

Determinants of Arterial Stiffness in Chronic Kidney Disease Stage 3
por: McIntyre, Natasha J., et al.
Publicado: (2013)

Is apocrine differentiation in breast carcinoma of prognostic significance?
por: Bundred, N. J., et al.
Publicado: (1990)

Barium Enema or Colonoscopy for the Investigation of Iron Deficiency Anaemia?
por: Sayer, J M, et al.
Publicado: (1999)

Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours
por: MacCallum, J, et al.
Publicado: (2000)

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.
por: MacCallum, J., et al.
Publicado: (1994)

Anthropomorphic Measurements That Include Central Fat Distribution Are More Closely Related with Key Risk Factors than BMI in CKD Stage 3
por: Evans, Philip D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g24ts2rflrp30jl0d1l3dph7f3